Surgeon-Scientist Research Training in Injury Pathobiology and Outcomes In Critical Illness

外科医生科学家损伤病理学和危重疾病结果研究培训

基本信息

  • 批准号:
    10555523
  • 负责人:
  • 金额:
    $ 8.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract The urgent need to refill the physician-scientist pipeline by training the next generation of physicians in basic and translational laboratory and applied clinical research has been widely recognized. A declining number of surgeon-scientists, however, threatens future advancement of surgical practice. The overall goal of this training program is to train the next generation of surgeon-scientists, who have the knowledge, skillsets and motivation to perform translationally relevant and meaningful research that will lead to significant improvements in patient outcomes. Our training program seeks applications from surgery residents interested in a 2-year full-time research training centered on injury pathobiology and outcomes in critical illness, a broad research arena essential for all surgical specialties. Each year, 1 trainee, who has typically completed 3 years of surgery residency, will be recruited primarily from a large pool of diverse and highly talented applicants for the general surgery and the integrated vascular surgery residency programs in the Department of Surgery, Morsani College of Medicine at University of South Florida (USF). The central hub of our training program is the Division of Surgical Research (DSR) in the DOS. Experienced investigators in the DSR, alongside carefully selected investigators from 5 other USF departments will form the training faculty. The training faculty is composed of 14 individuals who are committed to the research training of young surgeons, have an establish track record of extramural funding related to various aspects of injury pathobiology and outcomes in critical illness, and currently hold more than 30 NIH/VA awards as principal investigators. Many of our training faculty are physician scientists, which provides our trainees with critical experience and knowledge in both medical and basic sciences. Based on the experience of the MPI/PDs as PIs of previous T32 training programs at other institutions, we propose an optimized training plan to provide trainees with intensive state-of-the-art training in responsible conduct of rigorous and reproducible research that is guided by individual development plans. While trainees will select a scientific mentor of their choice, all trainees will be required to develop written research proposals and progress reports, to give formal research presentations, to participate in seminars, journal clubs and in didactic course work in biomedical data analysis and responsible conduct of research. In addition, trainees will have the opportunity to obtain additional graduate degrees/certifications in health informatics or health care analytics. We have the infrastructure, resources, expertise and motivation to provide our trainees with advanced and individualized research training in a vibrant scientific environment. We believe that our training program will ultimately provide the society with much needed surgeon-scientists, who will be at the forefront of clinical practice in the future.
项目摘要/摘要 迫切需要通过培训基本和基本医师的下一代医师来补充医师科学家管道 转化实验室和应用临床研究已得到广泛认可。数量下降 然而,外科医生科学家威胁着未来的手术实践进步。这项培训的总体目标 计划是培训具有知识,技能和动力的下一代外科医生科学家 进行翻译相关和有意义的研究,这将导致患者的重大改善 结果。我们的培训计划从对全职2年感兴趣的手术居民中寻求申请 研究培训集中于病理生物学和重症疾病的结果,这是一个广泛的研究领域 对于所有手术专业必不可少的。每年,有1名学员,他们通常完成了3年的手术 居住权将主要是从一大批多样化和高度才华的申请人中招募的 莫萨尼学院外科手术和综合血管外科住院医师计划 南佛罗里达大学(USF)的医学。我们培训计划的中心枢纽是 DOS中的手术研究(DSR)。 DSR的经验丰富的调查员以及精心挑选的 来自其他5个USF部门的调查人员将组成培训学院。培训教师由14个组成 致力于年轻外科医生的研究培训的个人,有建立的往绩 与伤害病理生物学和危重疾病的各个方面有关的各个方面的壁外资金,目前 担任首席研究人员的30多个NIH/VA奖。我们的许多培训教师是医师科学家, 这为学员提供了医学和基础科学方面的重要经验和知识。基于 关于MPI/PD作为其他机构以前T32培训计划的PI的经验,我们建议 优化的培训计划,为受训人员提供负责任的最新培训 由个人发展计划指导的严格且可重复的研究。而学员会选择一个 他们选择的科学导师,所有学员将被要求制定书面研究建议和进步 报告,进行正式的研究演讲,参加研讨会,期刊俱乐部和教学课程 生物医学数据分析和负责任的研究的工作。此外,学员将有 获得健康信息学或医疗保健分析方面的额外研究生学位/认证的机会。我们 拥有基础架构,资源,专业知识和动力,以为我们的受训者提供高级和 充满活力的科学环境中的个性化研究培训。我们相信我们的培训计划将 最终为社会提供急需的外科医生科学家,他们将处于临床实践的最前沿 将来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL C KUO其他文献

PAUL C KUO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL C KUO', 18)}}的其他基金

Aptamer targeting of osteopontin in hepatocellular cancer
适体靶向肝细胞癌中的骨桥蛋白
  • 批准号:
    8298389
  • 财政年份:
    2012
  • 资助金额:
    $ 8.42万
  • 项目类别:
Aptamer targeting of osteopontin in hepatocellular cancer
适体靶向肝细胞癌中的骨桥蛋白
  • 批准号:
    8520257
  • 财政年份:
    2012
  • 资助金额:
    $ 8.42万
  • 项目类别:
Redox-mediated p300 regulation of hepatocyte NF-kB
氧化还原介导的 p300 对肝细胞 NF-kB 的调节
  • 批准号:
    7090179
  • 财政年份:
    2006
  • 资助金额:
    $ 8.42万
  • 项目类别:
Redox-mediated p300 regulation of hepatocyte NF-kB
氧化还原介导的 p300 对肝细胞 NF-kB 的调节
  • 批准号:
    7232456
  • 财政年份:
    2006
  • 资助金额:
    $ 8.42万
  • 项目类别:
Training in the Biology of Injury and Inflammation
损伤和炎症生物学培训
  • 批准号:
    7089022
  • 财政年份:
    2004
  • 资助金额:
    $ 8.42万
  • 项目类别:
Training in the Biology of Injury and Inflammation
损伤和炎症生物学培训
  • 批准号:
    7560086
  • 财政年份:
    2004
  • 资助金额:
    $ 8.42万
  • 项目类别:
Training in the Biology of Injury and Inflammation
损伤和炎症生物学培训
  • 批准号:
    7263153
  • 财政年份:
    2004
  • 资助金额:
    $ 8.42万
  • 项目类别:
Training in the Biology of Injury and Inflammation
损伤和炎症生物学培训
  • 批准号:
    6909123
  • 财政年份:
    2004
  • 资助金额:
    $ 8.42万
  • 项目类别:
Training in the Biology of Injury and Inflammation
损伤和炎症生物学培训
  • 批准号:
    6697374
  • 财政年份:
    2004
  • 资助金额:
    $ 8.42万
  • 项目类别:
Training in the Biology of Injury and Inflammation
损伤和炎症生物学培训
  • 批准号:
    7454240
  • 财政年份:
    2004
  • 资助金额:
    $ 8.42万
  • 项目类别:

相似国自然基金

脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
  • 批准号:
    82371631
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
  • 批准号:
    82371150
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
  • 批准号:
    82371825
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目

相似海外基金

Predicting the Absence of Serious Bacterial Infection in the PICU
预测 PICU 中不存在严重细菌感染
  • 批准号:
    10806039
  • 财政年份:
    2023
  • 资助金额:
    $ 8.42万
  • 项目类别:
Recovering Together after Cardiac Arrest: A dyadic mind-body intervention for emotional distress in cardiac arrest survivors and their informal caregivers
心脏骤停后一起康复:针对心脏骤停幸存者及其非正式护理人员情绪困扰的二元身心干预
  • 批准号:
    10723275
  • 财政年份:
    2023
  • 资助金额:
    $ 8.42万
  • 项目类别:
Colorado APS Clinical Center
科罗拉多 APS 临床中心
  • 批准号:
    10645992
  • 财政年份:
    2023
  • 资助金额:
    $ 8.42万
  • 项目类别:
Identification of sub-phenotypes of severely ill burn patients and risk for secondary sepsis: SEPSISBURN
识别严重烧伤患者的亚表型和继发性败血症的风险:SEPSISBURN
  • 批准号:
    10720049
  • 财政年份:
    2023
  • 资助金额:
    $ 8.42万
  • 项目类别:
Accurate and Reliable Diagnostics for Injured Children: Machine Learning for Ultrasound
为受伤儿童提供准确可靠的诊断:超声机器学习
  • 批准号:
    10572582
  • 财政年份:
    2023
  • 资助金额:
    $ 8.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了